Genetic Research

 
Stock Quotes for Genetic Research top ^
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Core
Sign-up for gene investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Core
Sign-up for gntlf investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Core
Sign-up for gntlf investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Type: Speculative Growth
Sign-up for iliu investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Value
  • Stock Type: Speculative Growth
Sign-up for iliu investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Aggressive Growth
  • Morningstar Rating: 2 Stars
Sign-up for mygn investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Value
  • Stock Type: Slow Growth
Sign-up for rgdx investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for nlnk investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Type: Distressed
Sign-up for ccyg investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Mid Growth
  • Stock Type: Speculative Growth
  • Morningstar Rating: 4 Stars
Sign-up for sgen investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Type: Distressed
Sign-up for atos investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Mid Growth
  • Stock Type: Speculative Growth
  • Morningstar Rating: 4 Stars
Sign-up for sgen investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Aggressive Growth
  • Morningstar Rating: 2 Stars
Sign-up for mygn investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for nlnk investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Type: Distressed
Sign-up for ccyg investment picks
  • Industry: Diagnostics & Research
  • Sector: Healthcare
  • Stock Style: Small Value
  • Stock Type: Slow Growth
Sign-up for rgdx investment picks

 
News Articles for Genetic Research top ^
Seattle Genetics, Inc. (Nasdaq: SGEN) today reported financial results for the third quarter and nine months ended September 30, 2014.
Sign-up for Seattle Genetics Reports Third Quarter 2014 Financial Results investment picks
Seattle Genetics, Inc. (Nasdaq:SGEN) and Bristol-Myers Squibb Company (NYSE:BMY) today announced that the companies have entered into a clinical trial collaboration agreement to evaluate the investigational combination of Seattle Genetics’ antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin) and Bristol-Myers Squibb’s immunotherapy Opdivo (nivolumab) in two planned Phase 1/2 clinical trials.
Sign-up for Seattle Genetics and Bristol-Myers Squibb Announce Clinical Collaboration to Evaluate Combination of Adcetris® (Brentuximab Vedotin) and Opdivo® (Nivolumab) in Hematologic Malignancies investment picks
AMES, Iowa, Nov.
Sign-up for NewLink Genetics Corporation Reports Third Quarter 2014 Financial Results investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and NewLink Genetics Corporation (NASDAQ:NLNK), announced today that they have entered into an exclusive worldwide license agreement to research, develop, manufacture, and distribute NewLink’s investigational rVSV-EBOV (Ebola) vaccine candidate.
Sign-up for Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement for Investigational Ebola Vaccine investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Genetic Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Generation Assets  |  Next: Genomics Research